Last reviewed · How we verify
NCT06744387
Anterolateral Tigh (ALT) Flaps Oxygenation Monitoring by NIRS
trial testing clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy in Reconstructive Flap Surgery in 20 participants. Currently enrolling.
30 November 2026
Quick facts
| Lead sponsor | University Hospital, Antwerp |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 3 March 2025 |
| Primary completion | 30 November 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy
Conditions studied
- Reconstructive Flap Surgery — all drugs for Reconstructive Flap Surgery →
- Fasciocutaneous Anterolateral Thigh Flap — all drugs for Fasciocutaneous Anterolateral Thigh Flap →
- Postoperative Monitoring — all drugs for Postoperative Monitoring →
- Flap Ischemia — all drugs for Flap Ischemia →
Sponsor
University Hospital, Antwerp
Who can join
18 and older, any sex, with Reconstructive Flap Surgery or Fasciocutaneous Anterolateral Thigh Flap. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, by employing the gold standard approach: intermittent assessment of clinical parameters (flap's color, temperature, skin turgor and capillary refill time) combined with Doppler techniques, alongside continuous tissue oxygenation measurements obtained using the CASMED FORE-SIGHT ELITE monitor.The main objective of the study is to provide preliminary data on potential cut-off values indicative of flap failure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06744387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Antwerp trials
Trials by the same sponsor.
- NCT07455422 — A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurr · NA · not yet recruiting
- NCT07020715 — A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis · Phase 2 · not yet recruiting
- NCT07443761 — Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital. · active not recruiting
- NCT06372847 — DISE-HNS Effect Study · NA · recruiting
- NCT07189091 — CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06744387 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Antwerp
- Last refreshed: 5 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06744387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing